HHS · trading date Oct 14, 2026 · previous close $4.39 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$159.57M
Net income
-$811.0K
Total assets
$91.83M
Total liabilities
$71.30M
Stockholders' equity
$20.53M
Cash & equivalents
$5.58M
Operating income
$386.0K
Operating cash flow
-$1.74M
Capital expenditures
$2.76M
Fiscal year 2025, via 10-K filed 2026-03-17.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
0.2%
Net margin
-0.5%
Free cash flow
-$4.49M
Free cash flow margin
-2.8%
Liabilities / assets
77.6%
Equity / assets
22.4%
CapEx / revenue
1.7%
Operating cash flow / net income
2.14×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Chelmsford, MA 01824
1 EXECUTIVE DRIVE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.